Asthma in infants and children

Area of Science:

• Pediatric Pulmonology
• Allergy and Immunology

Background:

• Asthma is the most prevalent chronic childhood illness, posing a significant burden on healthcare and education.
• A substantial proportion of childhood asthma cases (25-67%) continue into adulthood.
• Diagnosing childhood asthma can be challenging due to overlapping symptoms with common childhood illnesses like upper respiratory infections.

Purpose of the Study:

• To summarize current national and worldwide guidelines for childhood asthma management.
• To highlight the central role of inhaled corticosteroids in long-term asthma treatment for children.
• To discuss recent research advancements aimed at optimizing inhaled medication delivery and safety profiles.

Main Methods:

• Review and synthesis of updated national and international asthma management guidelines.
• Analysis of current therapeutic strategies for pediatric asthma.
• Examination of recent research focusing on inhalant drug delivery and bioavailability.

Main Results:

• Guidelines emphasize accurate diagnosis, severity assessment, and tailored pharmacologic therapy.
• Inhaled corticosteroids are the primary long-term treatment for pediatric asthma across all age groups.
• Research is actively exploring methods to enhance lung drug delivery and reduce systemic side effects.

Conclusions:

• Effective childhood asthma management requires adherence to updated guidelines and individualized treatment plans.
• Optimizing inhaled corticosteroid therapy is crucial for improving the benefit:risk ratio in pediatric asthma patients.
• Continued research into drug delivery systems holds promise for better asthma control and reduced adverse effects.